123 related articles for article (PubMed ID: 32707843)
1. AniScan Using Extracellular Cyclic AMP-Dependent Protein Kinase A as a Serum Biomarker Assay for the Diagnosis of Malignant Tumors in Dogs.
Lee JE; Song WJ; Lee H; Kim BG; Kim T; Lee C; Jang B; Youn HY; Choi US; Bhang DH
Sensors (Basel); 2020 Jul; 20(15):. PubMed ID: 32707843
[TBL] [Abstract][Full Text] [Related]
2. Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.
Ryu MO; Kim BG; Choi US; Baek KH; Song YK; Li Q; Seo KW; Ryeom S; Youn HY; Bhang DH
Vet Comp Oncol; 2019 Mar; 17(1):99-106. PubMed ID: 30411459
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of extracellular cyclic AMP-dependent protein kinase as a biomarker of cancer in dogs.
Bhang DH; Choi US; Kim BG; Lee SN; Lee S; Roh HS; Chung WJ; Jeon KO; Song WJ; Youn HY; Baek KH
Vet Comp Oncol; 2017 Dec; 15(4):1585-1589. PubMed ID: 28185388
[TBL] [Abstract][Full Text] [Related]
4. Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients.
Wang H; Li M; Lin W; Wang W; Zhang Z; Rayburn ER; Lu J; Chen D; Yue X; Shen F; Jiang F; He J; Wei W; Zeng X; Zhang R
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):789-95. PubMed ID: 17416772
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody cancer biomarker: extracellular protein kinase A.
Nesterova MV; Johnson N; Cheadle C; Bates SE; Mani S; Stratakis CA; Khan IU; Gupta RK; Cho-Chung YS
Cancer Res; 2006 Sep; 66(18):8971-4. PubMed ID: 16982736
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
Cho YS; Lee YN; Cho-Chung YS
Biochem Biophys Res Commun; 2000 Nov; 278(3):679-84. PubMed ID: 11095968
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.
Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H
J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206
[TBL] [Abstract][Full Text] [Related]
8. Serodiagnosis of multiple cancers using an extracellular protein kinase A autoantibody-based lateral flow platform.
Gul AR; Bal J; Xu P; Ghosh S; Yun T; Kailasa SK; Kim YH; Park TJ
Biosens Bioelectron; 2024 Feb; 246():115902. PubMed ID: 38056339
[TBL] [Abstract][Full Text] [Related]
9. Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma.
Kita T; Goydos J; Reitman E; Ravatn R; Lin Y; Shih WC; Kikuchi Y; Chin KV
Cancer Lett; 2004 May; 208(2):187-91. PubMed ID: 15142677
[TBL] [Abstract][Full Text] [Related]
10. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
Stefatić D; Riederer M; Balić M; Dandachi N; Stanzer S; Janesch B; Resel M; Ler D; Samonigg H; Bauernhofer T
Bosn J Basic Med Sci; 2008 Aug; 8(3):245-50. PubMed ID: 18816257
[TBL] [Abstract][Full Text] [Related]
11. Investigation of serum survivin in dogs suffering from cancer: a multicenter study.
Estaller A; Kessler M; Wehrend A; Gessler F; Hirschberger J; Neumann S
J Vet Sci; 2021 Nov; 22(6):e79. PubMed ID: 34697925
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody biomarker opens a new gateway for cancer diagnosis.
Nesterova M; Johnson N; Cheadle C; Cho-Chung YS
Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by extracellular protein kinase A.
Szkudlarek M; Bosio RM; Wu Q; Chin KV
Cancer Lett; 2009 Sep; 283(1):68-73. PubMed ID: 19368997
[TBL] [Abstract][Full Text] [Related]
14. Investigation of serum Ki-67 as a biomarker in tumor-bearing dogs.
Neumann S; Schuettler J; Frenz M; Kaup FJ; Gessler F
Res Vet Sci; 2017 Feb; 110():16-21. PubMed ID: 28159231
[TBL] [Abstract][Full Text] [Related]
15. Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.
Mani S; Goel S; Nesterova M; Martin RM; Grindel JM; Rothenberg ML; Zhang R; Tortora G; Cho-Chung YS
Ann N Y Acad Sci; 2003 Dec; 1002():252-62. PubMed ID: 14751840
[TBL] [Abstract][Full Text] [Related]
16. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
17. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH; Sio KM; Wu CH; Xia YY; Lee JJ; Hu CH; Liu CC; Lu CL; Cheng CL; Lin KH; Tomiyasu H; Wang YS; Lin CS
J Vet Intern Med; 2023; 37(6):2391-2401. PubMed ID: 37837297
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Interpreting gelatinase activity in tumor tissue and serum as a prognostic marker of naturally developing canine tumors.
Miya K; Misumi K; Miyoshi N; Arai K; Fujiki M; Kubota C; Sakamoto H
J Vet Med Sci; 2005 Aug; 67(8):769-75. PubMed ID: 16141663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
